Procarbazine

From Glioblastoma Treatments
Revision as of 05:11, 24 March 2024 by Lazy (talk | contribs) (Created page with "{{TreatmentInfo |drug_name=Procarbazine |FDA_approval=Yes |used_for=Glioblastoma |clinical_trial_phase=Not specified |common_side_effects=Hematological toxicity, nausea, and neurological effects |OS_with=Not specified |usefulness_rating=3 |notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness. |category=Other Chemotherapy and Cancer Drugs")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

{{TreatmentInfo |drug_name=Procarbazine |FDA_approval=Yes |used_for=Glioblastoma |clinical_trial_phase=Not specified |common_side_effects=Hematological toxicity, nausea, and neurological effects |OS_with=Not specified |usefulness_rating=3 |notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness. |category=Other Chemotherapy and Cancer Drugs

Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Procarbazine&oldid=109"